DRUGS MADE IN AMERICA ACQUISITION CORP.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $795.7K | $550.8K | $1.4K |
| FY2025 | $7.3M | $239.9M | $6.1K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $795.7K | $550.8K | $1.4K |
| FY2025 | $7.3M | $239.9M | $6.1K |